Charles Hooper - Apr 14, 2023 - Winnipeg, Manitoba
8 months ago
663
Charles Hooper worked for Merck when Ivermectin was first released. He explains that in a pandemic, repurposed drugs are important due to the long timeline for development of new drugs. Charles decided to study Ivermectin at the beginning of the pandemic. He reanalyzed 95 clinical studies involving 27 countries and 134,554 patients confirming decreased death (51%), mechanical ventilation, ICU admission and improved recovery.
For the complete witness testimony, transcript, exhibits and more, please visit https://nationalcitizensinquiry.ca/witness/charles-hooper
Testimony Code: 2304WPG210
Loading comments...
-
52:18
NCI Witness Testimonies
3 months agoCharles Hooper - Apr 14, 2023 - Winnipeg, Manitoba
8 -
10:19
NationalCitizensInquiryCA
8 months agoMichael MacIver - Apr 13, 2023 - Winnipeg, Manitoba
271 -
9:20
NCI Witness Testimonies
3 months agoCarley Walterson-Dupuis - Apr 14, 2023 - Winnipeg, Manitoba
8 -
10:19
NCI Witness Testimonies
3 months agoMichael MacIver - Apr 13, 2023 - Winnipeg, Manitoba
2 -
27:22
NCI Witness Testimonies
4 months agoRandy Schiller - Apr 20, 2023 - Saskatoon, Saskatchewan
16 -
13:15
NCI Witness Testimonies
3 months agoSteven Kiedyk - Apr 15, 2023 - Winnipeg, Manitoba
6 -
29:27
NCI Witness Testimonies
3 months agoMichael Welch - Apr 13, 2023 - Winnipeg, Manitoba
6 -
1:07:48
NCI Witness Testimonies
4 months agoJoseph Bourgault - Apr 20, 2023 - Saskatoon, Saskatchewan
10 -
25:45
NCI Witness Testimonies
3 months agoPatrick Allard - Apr 14, 2023 - Winnipeg, Manitoba
11 -
32:04
NCI Witness Testimonies
3 months agoMichelle Kucher - Apr 14, 2023 - Winnipeg, Manitoba
9